Aditya Jain il 03/04/2025

Antidiabetic activity of polyherbal formulations: a comprehensive review

Protoplasma. 2025 Apr 3. doi: 10.1007/s00709-025-02057-x. Online ahead of print.ABSTRACTDiabetes mellitus is a chronic condition marked by high blood glucose levels, resulting from either insufficient insulin production or poor insulin function. While conventional treatments have progressed, there i

Philip Home il 03/04/2025

Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta-analysis of non-Asian studies

Diabetes Obes Metab. 2025 Apr 2. doi: 10.1111/dom.16360. Online ahead of print.ABSTRACTAIMS: To estimate the relative treatment effect of iGlarLixi (a fixed-ratio combination of insulin glargine 100 U/mL plus lixisenatide) versus premixed insulin IDegAsp (insulin degludec plus insulin aspart) in peo

Miloš Vratarić il 02/04/2025

Changes in lipid metabolism in visceral rather than the subcutaneous adipose tissue depot attenuate metabolic disturbances in obesity-resistant mice fed a high-fat diet

J Nutr Biochem. 2025 Mar 31:109912. doi: 10.1016/j.jnutbio.2025.109912. Online ahead of print.ABSTRACTObesity is characterized by an enlargement of white adipose tissue caused by caloric excess. The depot-specific adaptation of white adipose tissue in individuals resistant to obesity despite a high-

Chuze Xu il 02/04/2025

The role of TNF in metabolic disorders and liver diseases

Cytokine. 2025 Apr 1;190:156933. doi: 10.1016/j.cyto.2025.156933. Online ahead of print.ABSTRACTTumor necrosis factor (TNF) is identified as a pro-inflammatory cytokine critical to the pathology of liver disease. In the carbohydrate metabolism, TNF has been demonstrated to impede the insulin signali